Overview
- Abbott and Google announced a multiyear agreement to combine ongoing glucose readings from Abbott’s Lingo device with Google Health’s platform and tools.
- Lingo is an over‑the‑counter continuous glucose monitor that Abbott introduced in September 2024 and that is built on the company’s FreeStyle Libre technology.
- Google Health will display Lingo glucose trends alongside data from Fitbit and other trackers so the AI‑enabled Health Coach can offer contextual, habit‑focused recommendations on nutrition, activity, sleep, and recovery.
- The partnership includes plans for a large real‑world metabolic health study that will link continuous glucose data with wearable, laboratory, and survey information, though study protocols and enrollment remain in development.
- Lingo integrations are slated to roll out in the Google Health app later in 2026 and the consumer and clinical impact will depend on how the companies handle study design, data governance, and user privacy.